Loading clinical trials...
Loading clinical trials...
A Phase I Trial of STA-4783 in Patients Receiving Paclitaxel for Treatment of Solid Tumors
Conditions
Interventions
STA-4783/paclitaxel
Locations
2
United States
Beth Israel-Deaconess Medical Center
Boston, Massachusetts, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
January 1, 2003
Primary Completion Date
October 1, 2004
Completion Date
October 1, 2004
Last Updated
March 6, 2014
NCT07159659
NCT07213804
NCT00026884
NCT07169851
NCT07191730
NCT06662786
Lead Sponsor
Synta Pharmaceuticals Corp.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions